• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

AGA supports making drugs more affordable for patients

Bioengineer by Bioengineer
August 16, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Bethesda, MD (Aug. 15, 2018) — Increasing out-of-pocket expenses can limit access for patients, putting them at risk. Improving affordability requires a multi-faceted approach from across the health care system, including health insurers, drug and biologic manufacturers, and pharmacy benefit managers. The American Gastroenterological Association (AGA) urges policymakers and stakeholders to improve the affordability of drugs using these five principles:

  • Decrease out-of-pocket expenses for patients, which limit access to necessary therapies and contribute to noncompliance, potentially increasing complications and costs.
  • Maintain reasonable incentives for innovation and development of better therapies. Although AGA advocates for reduced out-of-pocket costs for patients, solutions should not disincentive future innovation.
  • Increase cost transparency by enabling patients to easily and quickly identify how much they will pay out-of-pocket for treatments, including drugs and biologics, before receiving care.
  • Promote shared decision-making and encourage patients to ask questions and express values and opinions about their conditions and treatment options, including discussions about cost.
  • Boost competition, which is associated with lower drug and biologic prices, with the largest decreases occurring when there are multiple generic competitors.

###

Read AGA's complete principles online at http://www.gastro.org/advocacy-and-policy/issues-and-news/top-issues/drug-affordability-principles.

About the AGA Institute

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. http://www.gastro.org.

Like AGA on Facebook.

Follow us on Twitter @AmerGastroAssn.

Check out our videos on YouTube.

Join AGA on LinkedIn.

Media Contact

Arnulfo Moreno
[email protected]
301-941-9796
@AmerGastroAssn

http://www.gastro.org

Share13Tweet8Share2ShareShareShare2

Related Posts

PROGRESS trial evaluates droplet digital PCR for sepsis diagnosis and antibiotic use

August 20, 2026

Prostate cancer rewires amino acid metabolism, driving resistance to hormone therapy

August 20, 2026

Artery Damage Found in Twentysomethings Underscores Need for Early Heart Risk Checks

August 20, 2026

Key Indicators of Healthy Skeletal Muscle

August 20, 2026
Please login to join discussion

POPULAR NEWS

  • Correction: Non-native invasive trees abound in neotropical secondary forests, declining over time

    29 shares
    Share 12 Tweet 7
  • Programmable Topological Metasurfaces Bridge Trivial and Nontrivial States for Sensing, Communication

    29 shares
    Share 12 Tweet 7
  • PROGRESS trial evaluates droplet digital PCR for sepsis diagnosis and antibiotic use

    29 shares
    Share 12 Tweet 7
  • PolyU team develops TRUECAM to improve AI reliability in cancer diagnosis

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Correction: Non-native invasive trees abound in neotropical secondary forests, declining over time

Programmable Topological Metasurfaces Bridge Trivial and Nontrivial States for Sensing, Communication

PROGRESS trial evaluates droplet digital PCR for sepsis diagnosis and antibiotic use

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.